E-LIB Suche - Ergebnisse für: Yimer, Habte A.

1

A phase 3b study of venetoclax and azacitidine or decitabin..:

Manda, Sudhir ; Anz III, Bertrand M. ; Benton, Christopher...
Hematological Oncology. 42 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

2

Genomic landscape of patients in a phase II study of zanubr..:

Xu, Linlin ; Shadman, Mazyar ; Flinn, Ian W....
Haematologica. , 2024

Link: https://doi.org/10.3324/..

3

Plain language summary of zanubrutinib or ibrutinib in chro..:

Brown, Jennifer R ; Eichhorst, Barbara ; Hillmen, Peter...
Future Oncology. 20 (2024) 12 - p. 717-726 , 2024

Link: https://doi.org/10.2217/..

4

In-class transition (iCT) of proteasome inhibitor-based the..:

Rifkin, Robert M. ; Girnius, Saulius K. ; Noga, Stephen J....
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

5

P719: RANDOMIZED PHASE 1-2 STUDY TO ASSESS SAFETY AND EFFIC..:

Garcia-Manero, Guillermo ; Bachishvili, Kimo ; A. Griffiths, Elizabeth...
HemaSphere. 7 (2023) S3 - p. e551265b , 2023

Link: https://doi.org/10.1097/..

6

CT-045 Primary Results From OUTREACH: A Phase II Study of L..:

Linhares, Yuliya ; Freytes, Cesar ; Cherry, Mohamad...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S514-S515 , 2023

Link: https://doi.org/10.1016/..

7

PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO O..:

Girnius, Saulius K. ; Richter, Joshua ; Lyons, Roger M....
HemaSphere. 7 (2023) S3 - p. e149880d , 2023

Link: https://doi.org/10.1097/..

8

POSTER: MDS-641 Randomized Phase 1-2 Study to Assess Safety..:

Garcia-Manero, Guillermo ; Bachiashvili, Kimo ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S187 , 2023

Link: https://doi.org/10.1016/..

9

P1064: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DAC..:

Yasenchak, Chris ; Flinn, Ian W. ; Melear, Jason...
HemaSphere. 7 (2023) S3 - p. e5881312 , 2023

Link: https://doi.org/10.1097/..

10

Zanubrutinib in patients with treatment‐naïve or relapsed/r..:

Castillo, Jorge J ; Kingsley, Edwin C ; Narang, Mohit...
eJHaem. 4 (2023) 1 - p. 301-304 , 2023

Link: https://doi.org/10.1002/..

11

P-114 In-class transition (iCT) from parenteral bortezomib ..:

Girnius, Saulius ; Richter, Joshua ; Lyons, Roger...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S97-S98 , 2023

Link: https://doi.org/10.1016/..

12

MDS-641 Randomized Phase 1-2 Study to Assess Safety and Eff..:

Garcia-Manero, Guillermo ; Bachiashvili, Kimo ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S376-S377 , 2023

Link: https://doi.org/10.1016/..

13

POSTER: CT-045 Primary Results From OUTREACH: A Phase II St..:

Linhares, Yuliya ; Freytes, Cesar ; Cherry, Mohamad...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S233 , 2023

Link: https://doi.org/10.1016/..

14

Performance of a targeted methylation-based multi-cancer ea..:

Tang, W.H. Wilson ; Yimer, Habte ; Tummala, Mohan...
Preventive Medicine. 167 (2023) - p. 107384 , 2023

Link: https://doi.org/10.1016/..

15

POSTER: MM-465 In-Class Transition (iCT) from Parenteral Bo..:

Girnius, Saulius K. ; Richter, Joshua ; Lyons, Roger...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S221 , 2023

Link: https://doi.org/10.1016/..